Trader Note — 9349 total
PONY has added another 16% this week — yet short sellers are not budging, leaving the stock in the same unresolved standoff that defined last week's note. The price move is the headline. PONY closed at $10.83 on…
Palvella Therapeutics has given back the gains that made last week's bullish thesis look prescient — down 11% on the week to $104.67 — and the question now is whether the stubborn short base is finally being…
StandardAero enters the first week of June with two simultaneous shocks: a bellwether downgrade and a CEO change that together sent the stock down 8% on Tuesday alone. The catalyst was a Jefferies call filed Monday.…
BTC — the Grayscale Bitcoin Mini Trust — has had a rough week, sliding 11.4% to $29.72, and options traders are responding by pushing protective hedges to new territory. The clearest shift this week is in options…
WeRide Inc. enters June with a striking divergence: options traders are their most bullish in months, yet the stock trades at $7.75 — a fraction of where analysts think it belongs. The clearest signal this week is in…
VIK is drawing unusual levels of Street attention this week, with two fresh initiations landing in the past 48 hours even as options traders quietly reduce their defensive hedges. The most striking development is the…
GE Vernova heads into early June with a notable split signal: options traders are more defensive than at any point in recent memory, even as short interest remains modest by any absolute standard. The clearest tension…
Core Scientific enters June with shorts firmly on the back foot — a 43% one-month surge to $29.05 has forced the conversation away from bear fundamentals and squarely onto whether the Street's targets can keep…
NANO Nuclear Energy finds itself in an awkward middle ground: the squeeze that defined late May has partly unwound, availability has opened up, yet 19% of the float remains short and the stock has added another 5% this…
ARM has added another 25% this week alone, closing at $402.71 — and the gap between where the stock trades and where the Street thought it was going has never looked wider. The analyst community is scrambling to keep…
AESI heads into a pivotal stretch with a split signal: Raymond James just upgraded the stock to Outperform, yet short interest has been quietly climbing back toward its highs. The most consequential development this…
AXG is heading into its June 30 earnings date with a sharp reversal in short positioning — the very trend that defined last week's note has now flipped. Short interest has jumped 79% over the past week, rising from…
SS Innovations International just drew its first formal analyst coverage, with Lucid Capital Markets initiating at Buy and a $7 price target — 75% above Tuesday's close of $4.01. That headline is attention-grabbing.…
NXT has had a remarkable fortnight — up 16% on the week and 27% over the past month to close at $152.22, propelled by strong Q3 earnings and a wave of analyst target upgrades. The tension this week is a clean one: a…
Mineralys Therapeutics stumbled into a pivotal week — pricing a dilutive equity offering at a steep discount to buy back royalty obligations on lorundrostat, right as the FDA clock ticks louder. On June 3, the company…
Intuitive Machines has just reported — and the post-earnings picture looks meaningfully different from the pre-print setup that dominated four straight notes. The June 4 earnings event arrived with the stock at $39.57,…
OCS has fallen another 46% since Friday's trial-failure note — and the Street's response this week tells the real story. The stock closed at $12.29 on Tuesday, down 59% on the week and 55% over the past month. That…
ODD just endured its worst week in years — and the Street's response has been swift, unified, and unsparing. The stock closed Tuesday at $9.84, down 30% in a single session on June 2 and 19% on the week after Q1…
AMPX is caught in a genuine tug-of-war: the stock just posted its biggest weekly gain in months, a new analyst fired the opening shot with a bullish initiation, and the people running the company quietly sold into…
D-Wave Quantum has cleared the June 1 earnings hurdle with barely a scratch, and analysts responded the following morning by raising price targets — yet insiders who sold into the rally look increasingly prescient, and…
